FDA Chief Counsel Troy Resigns; Agency Says It Will Still Support Preemption

FDA will continue to protect its regulatory authority by supporting federal preeminence in state product liability suits following the departure of Chief Counsel Dan Troy, Acting Commissioner Lester Crawford said